Announcements Trials
Browse Landscape

Phase

Phase 2 90Phase 1 19Phase 1/2 17Phase NA 10Phase 3 9Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1CNS 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

fludarabine phosphate 5Cyclophosphamide 5Azacitidine 4Thiotepa 3Stem Cell Transplantation 3Melphalan 3Gemtuzumab 3Decitabine 3Cytarabine 3Busulfan 3venetoclax 2Radiotherapy 2Methylprednisolone 2Interferon alpha-2 2Injections 2Filgrastim 2Etoposide 2Emapalumab 2Cyclosporine 2Cladribine 2Antilymphocyte Serum 2vosaroxin 1vedolizumab 1trametinib 1tipifarnib 1thymoglobulin 1peginterferon alfa-2b 1peginterferon alfa-2a 1nilotinib 1midostaurin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Mycophenolic Acid × Myeloid × Clear all
NCT02707393 2021-04-15

Allogeneic Stem Cell Transplantation for Children With CML

St. Anna Kinderkrebsforschung

Phase 2/3 Completed
13 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡